- Pharmacists’ Expanded Authority to Administer Childhood Vaccines: What to Know (October 6, 2020)
- Eligible Outpatient Facilities of 340B Hospitals Can Now Bypass Registration Delays (June 5, 2020)
- Hospitals Fear Pandemic May Threaten Their Eligibility to Participate in the 340B Drug Program (May 29, 2020)
- PREP Act Immunity for Pharmacists Ordering COVID-19 Tests: New HHS OGC Advisory Opinion Addresses Conflicting State Laws (May 21, 2020)
- Attention 340B Hospitals: CMS Cost Data Survey Due May 15 Raises Important Compliance Questions (May 1, 2020)
- FDA Issues Sterile Compounding Pharmacy PPE Guidance (April 17, 2020)
- FEMA Restricts Export of PPE in Temporary Final Rule (April 10, 2020)
- A COVID-19 340B Update: OPA Updates Its GPO Prohibition Guidance and Other Outstanding 340B Program Issues (March 25, 2020)
- USP Publishes Guidance on Conserving PPE in Sterile Compounding and Compounding Hand-Sanitizer During COVID-19 Pandemic (March 23, 2020)
- COVID-19 Testing Update: Legal Considerations for Drive-Through Collection Sites, Diagnostic Testing Sites and Diagnostic Test Development (March 20, 2020)